Studying the metabolism of sorafenib (Nexavar) by OATP1B blockage in adult cancer patients. [Onderzoek naar het effect van OATP1B blokkade op de stofwisseling van sorafenib (Nexavar) bij volwassen patiënten met kanker.]

Trial Profile

Studying the metabolism of sorafenib (Nexavar) by OATP1B blockage in adult cancer patients. [Onderzoek naar het effect van OATP1B blokkade op de stofwisseling van sorafenib (Nexavar) bij volwassen patiënten met kanker.]

Completed
Phase of Trial: Phase I

Latest Information Update: 02 Jun 2015

At a glance

  • Drugs Sorafenib (Primary)
  • Indications Solid tumours
  • Focus Pharmacokinetics
  • Acronyms SORA-RIFA
  • Most Recent Events

    • 02 Jun 2015 Status changed from recruiting to completed as per Netherlands Trial Register.
    • 30 Aug 2013 New source identified and integrated: European Clinical Trials Database record.
    • 28 Aug 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top